Prosecution Insights
Prosecution Insights
Tech Center 2100 • Art Units: 2122 2154 2156 2161 2169 2179
This examiner grants 77% of resolved cases
Christopher J. Raab is an examiner in Tech Center 2100 and Art Unit 2122. The data shows 528 resolved cases, which provides a sample for understanding the examiner's workflow. This volume of 528 cases is an indicator of the examiner's established practices. Practitioners can use these figures to better prepare for the examination process in this specific art unit.
The allowance rate for this examiner is 76.7 percent. This figure indicates the probability of success for applicants. The interview lift is 14.3 percent, which is a factor for practitioners to consider. This 14.3 percent lift suggests that interviews are a productive way to address examiner concerns and move toward an allowance. It provides a boost to the 76.7 percent allowance rate, highlighting the value of direct communication.
The median days to allowance is 1229. This timeline is a metric for applicants to use when forecasting the duration of their patent prosecution. The 1229 day median, when viewed with the 76.7 percent allowance rate, helps set expectations for the process. These data points are essential for making informed strategic decisions for applications assigned to this examiner in Tech Center 2100.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18980925 | AUTOMATED CONTACT CREATION BASED ON CONTENT COMMUNICATIONS | Final Rejection | Adeia Guides Inc. |
| 18523095 | TERRAIN DATABASE ADAPTIVE RESOLUTION METHOD | Non-Final OA | Rockwell Collins, Inc. |
| 19161741 | ESTIMATION DEVICE | Non-Final OA | NTT DOCOMO, INC. |
| 19347529 | SYSTEMS AND METHODS FOR BLOCK PROCESSING TIME SERIES INTEGRATION | Non-Final OA | MongoDB, Inc. |
| 18929483 | NEURAL NETWORK MODIFICATIONS TO QUERIES | Non-Final OA | NVIDIA Corporation |
| 19068675 | CHART CREATION BASED ON A DATA PROCESSING PACKAGE | Final Rejection | Cisco Technology, Inc. |
| 18502813 | SYSTEM AND METHOD FOR ACHIEVING GOALS | Non-Final OA | Data Health Partners, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy